- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05051800
Enhancing Coping and Communication in Children With Cancer and Their Parents (ALSF)
September 9, 2021 updated by: Bruce Compas, Vanderbilt University
Enhancing Coping and Communication in Children With Cancer and Their Parents: A Novel Internet Intervention
Childhood cancer patients and their parents are faced with significant stress at the time of diagnosis, during treatment, and over the course of recovery.
The stress of cancer and its treatment can lead to significant emotional distress for many families.
However, most families do not have access to programs that offer support for coping with cancer-related stress.
The proposed work will address this gap by testing of the possible benefits of a novel internet delivered program to support children with cancer and their parents in coping with and communicating about a child's cancer.
The research team includes experts from Vanderbilt University and Nationwide Children's Hospital with experience in pediatric oncology; stress, coping, and family communication in pediatric cancer; internet interventions in pediatric populations; and family-focused interventions to build coping and parenting skills.
The study will test the effects of this program in 150 families of children with newly diagnosed cancer on reducing emotional distress up to 12 months after participation in the program.
This project has the potential to lead to an evidence-based program to improve quality of life and resilience in children with cancer and their parents that can be easily and widely disseminated.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Childhood cancer patients and their parents are faced with significant stress at the time of diagnosis, during treatment, and over the course of recovery.
The stress of cancer and its treatment can lead to significant emotional distress for many families.
However, most families do not have access to programs that offer support for coping with cancer-related stress.
The proposed work will address this gap by testing of the possible benefits of a novel internet delivered program to support children with cancer and their parents in coping with and communicating about a child's cancer.
This online program includes modules to teach parenting, communication and coping skills to parents of children with cancer, and coping skills to their children who have been recently diagnosed with cancer.
The research team includes experts from Vanderbilt University and Nationwide Children's Hospital with experience in pediatric oncology; stress, coping, and family communication in pediatric cancer; internet interventions in pediatric populations; and family-focused interventions to build coping and parenting skills.
The study will test the effects of this program in 150 families of children with newly diagnosed cancer on reducing emotional distress up to 12 months after participation in the program.
This project has the potential to lead to an evidence-based program to improve quality of life and resilience in children with cancer and their parents that can be easily and widely disseminated.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Tennessee
-
Nashville, Tennessee, United States, 37203
- Vanderbilt University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 15 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Child from ages 10 to 17 years old who has been diagnosed with cancer
Exclusion Criteria:
- Significant intellectual disability that would interfere with completing the online program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Early Intervention
Families will receive the online program to support coping and communication near the time of a child's cancer diagnosis
|
Parents and children will access online materials designed to support the use of effective ways to cope with the diagnosis and treatment of cancer and to support open and communication.
|
Active Comparator: Delayed Intervention
Families will receive the online program to support coping and communication approximately 6 months after a child's cancer diagnosis
|
Parents and children will access online materials designed to support the use of effective ways to cope with the diagnosis and treatment of cancer and to support open and communication.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Total Behavior Problems on the Child Behavior Checklist from baseline to 6 months
Time Frame: The Child Behavior Checklist will be completed near the time of entry into the study and repeated at 6 month follow ups
|
Change in parents' report on the Child Behavior Checklist (a measure of their children's total emotional and behavioral problems).
|
The Child Behavior Checklist will be completed near the time of entry into the study and repeated at 6 month follow ups
|
Change in Total Behavior Problems on the Youth Self Report from baseline to 6 months
Time Frame: This measure will be completed near the time of entry into the study and repeated at 6 month follow ups
|
Change in children's report on the Youth Self Report (a measure of their children's total emotional and behavioral problems).
|
This measure will be completed near the time of entry into the study and repeated at 6 month follow ups
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2019
Primary Completion (Actual)
June 30, 2021
Study Completion (Actual)
June 30, 2021
Study Registration Dates
First Submitted
June 18, 2019
First Submitted That Met QC Criteria
September 9, 2021
First Posted (Actual)
September 21, 2021
Study Record Updates
Last Update Posted (Actual)
September 21, 2021
Last Update Submitted That Met QC Criteria
September 9, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRB 170111
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pediatric Cancer
-
Emory UniversityNational Cancer Institute (NCI)Recruiting
-
Ann & Robert H Lurie Children's Hospital of ChicagoSilicon Valley Community FoundationUnknownCancer | Pediatric CancerUnited States
-
University of BirminghamCompletedCancer | Pediatric ALL | Pediatric Solid Tumor | Pediatric AMLUnited Kingdom, Australia, Netherlands
-
Alexandria UniversityCompletedPediatric Cancer | Invasive CancerEgypt
-
University of California, San DiegoNational Cancer Institute (NCI); Dana-Farber Cancer Institute; University of... and other collaboratorsNot yet recruiting
-
Immune Oncology Research InstituteRecruitingContinuous Infusion of First-Generation 5-HT3 Receptor Antagonists in Combination With DexamethasonePediatric CancerArmenia
-
Connecticut Children's Medical CenterThe Hospital for Sick ChildrenRecruitingPediatric CancerUnited States
-
University of Michigan Rogel Cancer CenterRecruitingPediatric CancerUnited States
-
Erin RowellRecruiting
-
Giselle ShollerRecruiting
Clinical Trials on Online Program to Support Coping and Communication in Families
-
US Department of Veterans AffairsNational Cancer Institute (NCI)CompletedNeoplasms | AgingUnited States
-
Kastamonu UniversityCompletedLow Back Pain | Pregnancy Related | Nurse's RoleTurkey
-
Yosuke UchitomiRecruitingAdvanced Cancer | Recurrent Cancer | End of Life CareJapan
-
Boston University Charles River CampusNational Cancer Institute (NCI)CompletedChildhood Cancer | Posttraumatic Stress Disorder | Pediatric Cancer | SiblingsUnited States
-
University of Jyvaskylathe Finnish Cultural Foundation, Central Finland Regional FundCompleted
-
University of JyvaskylaAcademy of FinlandCompleted
-
The Miriam HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Not yet recruiting
-
Wake Forest University Health SciencesCompletedObesity, ChildhoodUnited States
-
Wake Forest University Health SciencesCompletedObesity, ChildhoodUnited States
-
Omada Health, Inc.Palo Alto Medical Foundation; Sutter HealthTerminatedType 2 DiabetesUnited States